ENDRA Capital Expenditures vs Change To Account Receivables Analysis

NDRA Stock

USD 5.71 0.34 5.62%

ENDRA Life financial indicator trend analysis is much more than just examining ENDRA Life Sciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ENDRA Life Sciences is a good investment. Please check the relationship between ENDRA Life Capital Expenditures and its Change To Account Receivables accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Capital Expenditures vs Change To Account Receivables

Capital Expenditures vs Change To Account Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ENDRA Life Sciences Capital Expenditures account and Change To Account Receivables. At this time, the significance of the direction appears to have almost no relationship.

The correlation between ENDRA Life's Capital Expenditures and Change To Account Receivables is 0.16. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Change To Account Receivables in the same time period over historical financial statements of ENDRA Life Sciences, assuming nothing else is changed. The correlation between historical values of ENDRA Life's Capital Expenditures and Change To Account Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of ENDRA Life Sciences are associated (or correlated) with its Change To Account Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Account Receivables has no effect on the direction of Capital Expenditures i.e., ENDRA Life's Capital Expenditures and Change To Account Receivables go up and down completely randomly.

Correlation Coefficient

0.16

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by ENDRA Life Sciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of ENDRA Life operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Change To Account Receivables

Most indicators from ENDRA Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ENDRA Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At present, ENDRA Life's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 574.37, whereas Selling General Administrative is forecasted to decline to about 3.7 M.

	2023	2024 (projected)
Non Recurring	258.8K	230.0K
Reconciled Depreciation	282.0K	180.8K

Non Recurring Reconciled Depreciation

ENDRA Life fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Other Liab	Non Current Liabilities Total	Short Long Term Debt Total
Total Assets		0.8	0.75	0.99	0.97	0.79	-0.93	-0.8	0.78	0.96	0.31	0.96	0.77	0.37	0.86	0.53	0.74	0.87	0.83	0.68	0.98	0.75	0.74	-0.19	0.83	-0.61
Other Current Liab	0.8		0.69	0.77	0.75	0.87	-0.63	-0.79	0.58	0.66	0.27	0.66	0.74	0.36	0.79	0.66	0.58	0.84	0.75	0.7	0.78	0.42	0.78	-0.14	0.75	-0.34
Total Current Liabilities	0.75	0.69		0.66	0.64	0.74	-0.66	-0.66	0.87	0.73	0.24	0.73	0.54	0.27	0.71	0.39	0.47	0.69	0.98	0.57	0.75	0.42	0.65	-0.15	0.66	-0.41
Total Stockholder Equity	0.99	0.77	0.66		0.98	0.75	-0.94	-0.78	0.73	0.95	0.31	0.95	0.76	0.37	0.84	0.53	0.74	0.85	0.74	0.65	0.97	0.76	0.71	-0.18	0.8	-0.64
Net Tangible Assets	0.97	0.75	0.64	0.98		0.72	-0.89	-0.82	0.69	0.9	0.41	0.9	0.8	0.47	0.87	0.59	0.7	0.9	0.72	0.75	0.91	0.73	0.77	-0.24	0.77	-0.65
Property Plant And Equipment Net	0.79	0.87	0.74	0.75	0.72		-0.62	-0.78	0.61	0.67	0.29	0.67	0.75	0.36	0.79	0.6	0.74	0.82	0.83	0.78	0.77	0.65	0.88	-0.15	0.9	-0.07
Net Debt	-0.93	-0.63	-0.66	-0.94	-0.89	-0.62		0.55	-0.8	-0.98	-0.05	-0.98	-0.53	-0.09	-0.67	-0.22	-0.66	-0.66	-0.72	-0.43	-0.96	-0.73	-0.51	-0.04	-0.72	0.66
Retained Earnings	-0.8	-0.79	-0.66	-0.78	-0.82	-0.78	0.55		-0.54	-0.64	-0.76	-0.64	-0.97	-0.81	-0.98	-0.9	-0.49	-0.95	-0.73	-0.9	-0.69	-0.53	-0.89	0.62	-0.74	0.43
Accounts Payable	0.78	0.58	0.87	0.73	0.69	0.61	-0.8	-0.54		0.83	0.17	0.83	0.39	0.18	0.63	0.23	0.4	0.58	0.85	0.44	0.79	0.4	0.51	-0.11	0.56	-0.61
Cash	0.96	0.66	0.73	0.95	0.9	0.67	-0.98	-0.64	0.83		0.17	1.0	0.62	0.21	0.75	0.31	0.66	0.7	0.79	0.48	0.98	0.76	0.56	-0.1	0.77	-0.65
Non Current Assets Total	0.31	0.27	0.24	0.31	0.41	0.29	-0.05	-0.76	0.17	0.17		0.17	0.73	0.99	0.7	0.82	0.04	0.57	0.26	0.67	0.16	0.17	0.56	-0.94	0.26	-0.3
Cash And Short Term Investments	0.96	0.66	0.73	0.95	0.9	0.67	-0.98	-0.64	0.83	1.0	0.17		0.62	0.21	0.75	0.31	0.66	0.7	0.79	0.48	0.98	0.76	0.56	-0.1	0.77	-0.65
Common Stock Total Equity	0.77	0.74	0.54	0.76	0.8	0.75	-0.53	-0.97	0.39	0.62	0.73	0.62		0.79	0.95	0.88	0.54	0.91	0.64	0.84	0.67	0.64	0.83	-0.61	0.78	-0.35
Common Stock Shares Outstanding	0.37	0.36	0.27	0.37	0.47	0.36	-0.09	-0.81	0.18	0.21	0.99	0.21	0.79		0.74	0.89	0.12	0.64	0.3	0.71	0.22	0.2	0.61	-0.92	0.3	-0.33
Capital Surpluse	0.86	0.79	0.71	0.84	0.87	0.79	-0.67	-0.98	0.63	0.75	0.7	0.75	0.95	0.74		0.8	0.5	0.93	0.78	0.85	0.78	0.63	0.85	-0.57	0.81	-0.49
Inventory	0.53	0.66	0.39	0.53	0.59	0.6	-0.22	-0.9	0.23	0.31	0.82	0.31	0.88	0.89	0.8		0.35	0.78	0.44	0.78	0.41	0.25	0.74	-0.72	0.47	-0.3
Other Current Assets	0.74	0.58	0.47	0.74	0.7	0.74	-0.66	-0.49	0.4	0.66	0.04	0.66	0.54	0.12	0.5	0.35		0.59	0.56	0.51	0.75	0.76	0.61	0.07	0.67	-0.11
Other Stockholder Equity	0.87	0.84	0.69	0.85	0.9	0.82	-0.66	-0.95	0.58	0.7	0.57	0.7	0.91	0.64	0.93	0.78	0.59		0.76	0.93	0.76	0.59	0.94	-0.35	0.79	-0.45
Total Liab	0.83	0.75	0.98	0.74	0.72	0.83	-0.72	-0.73	0.85	0.79	0.26	0.79	0.64	0.3	0.78	0.44	0.56	0.76		0.64	0.82	0.56	0.73	-0.15	0.79	-0.36
Property Plant And Equipment Gross	0.68	0.7	0.57	0.65	0.75	0.78	-0.43	-0.9	0.44	0.48	0.67	0.48	0.84	0.71	0.85	0.78	0.51	0.93	0.64		0.53	0.49	0.98	-0.42	0.69	-0.21
Total Current Assets	0.98	0.78	0.75	0.97	0.91	0.77	-0.96	-0.69	0.79	0.98	0.16	0.98	0.67	0.22	0.78	0.41	0.75	0.76	0.82	0.53		0.75	0.62	-0.08	0.81	-0.58
Common Stock	0.75	0.42	0.42	0.76	0.73	0.65	-0.73	-0.53	0.4	0.76	0.17	0.76	0.64	0.2	0.63	0.25	0.76	0.59	0.56	0.49	0.75		0.56	-0.09	0.85	-0.15
Property Plant Equipment	0.74	0.78	0.65	0.71	0.77	0.88	-0.51	-0.89	0.51	0.56	0.56	0.56	0.83	0.61	0.85	0.74	0.61	0.94	0.73	0.98	0.62	0.56		-0.32	0.78	-0.17
Other Liab	-0.19	-0.14	-0.15	-0.18	-0.24	-0.15	-0.04	0.62	-0.11	-0.1	-0.94	-0.1	-0.61	-0.92	-0.57	-0.72	0.07	-0.35	-0.15	-0.42	-0.08	-0.09	-0.32		-0.14	0.27
Non Current Liabilities Total	0.83	0.75	0.66	0.8	0.77	0.9	-0.72	-0.74	0.56	0.77	0.26	0.77	0.78	0.3	0.81	0.47	0.67	0.79	0.79	0.69	0.81	0.85	0.78	-0.14		-0.13
Short Long Term Debt Total	-0.61	-0.34	-0.41	-0.64	-0.65	-0.07	0.66	0.43	-0.61	-0.65	-0.3	-0.65	-0.35	-0.33	-0.49	-0.3	-0.11	-0.45	-0.36	-0.21	-0.58	-0.15	-0.17	0.27	-0.13

Click cells to compare fundamentals

ENDRA Life Account Relationship Matchups

ENDRA Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.2M	8.8M	12.9M	9.3M	6.8M	6.6M
Other Current Liab	430.1K	430.8K	488.1K	909.1K	340.4K	357.6K
Total Current Liabilities	2.1M	986.7K	1.5M	1.7M	903.1K	1.2M
Total Stockholder Equity	4.8M	7.2M	10.8M	7.2M	5.7M	5.2M
Net Tangible Assets	4.8M	7.2M	10.8M	7.2M	8.3M	5.1M
Property Plant And Equipment Net	641.2K	551.3K	774.5K	741.5K	465.9K	510.7K
Net Debt	(5.5M)	(6.5M)	(8.8M)	(4.3M)	(2.4M)	(2.6M)
Retained Earnings	(45.2M)	(57.3M)	(68.7M)	(81.9M)	(91.9M)	(87.3M)
Accounts Payable	1.3M	402.9K	791.1K	614.0K	360.4K	569.7K
Cash	6.2M	7.2M	9.5M	4.9M	2.8M	4.7M
Non Current Assets Total	641.2K	551.3K	780.5K	747.5K	3.7M	3.9M
Cash And Short Term Investments	6.2M	7.2M	9.5M	4.9M	2.8M	4.7M
Common Stock Total Equity	392.0	742.0	842.0	3.4K	3.9K	4.1K
Common Stock Shares Outstanding	375.0K	959.6K	2.0M	2.9M	9.0M	9.5M
Liabilities And Stockholders Equity	7.2M	8.8M	12.9M	9.3M	6.8M	6.6M
Capital Surpluse	23.2M	33.9M	49.9M	64.5M	74.2M	77.9M
Inventory	113.4K	589.6K	1.3M	2.6M	2.6M	2.8M
Other Current Assets	130.7K	396.8K	2.7M	992.9K	198.9K	189.0K
Other Stockholder Equity	49.9M	64.5M	79.5M	89.1M	97.6M	51.6M
Total Liab	2.4M	1.6M	2.1M	2.1M	1.1M	1.4M
Property Plant And Equipment Gross	641.2K	551.3K	774.5K	741.5K	1.1M	576.8K
Total Current Assets	6.5M	8.2M	12.1M	8.5M	3.0M	5.7M
Accumulated Other Comprehensive Income	43.5K	10.8K	13.9K	6.1K	5.2K	5.5K
Common Stock	842.0	3.4K	4.3K	317.0	1.0K	1.3K
Property Plant Equipment	641.2K	551.3K	774.5K	741.5K	852.7K	510.5K
Net Receivables	116.7K	390.8K	(1.3M)	(2.6M)	(2.4M)	(2.2M)
Non Current Liabilities Total	342.8K	609.0K	546.6K	365.9K	192.1K	251.3K
Short Long Term Debt Total	707.1K	685.5K	679.0K	546.6K	394.4K	452.9K
Short Term Debt	364.3K	153.0K	264.7K	180.7K	202.3K	211.5K
Net Invested Capital	5.1M	7.5M	10.8M	7.2M	5.7M	7.5M
Net Working Capital	4.5M	7.2M	10.6M	6.8M	2.1M	2.0M
Capital Stock	843.0	3.4K	4.3K	318.0	1.0K	1.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:

How To Invest In ENDRA

Details

Is ENDRA Stock a good investment?

Details

What is ENDRA Life's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

-3 K

Return On Assets

(0.61)

Return On Equity

(1.20)

The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ENDRA Capital Expenditures vs Change To Account Receivables Analysis

Capital Expenditures vs Change To Account Receivables

Capital Expenditures vs Change To Account Receivables Correlation Analysis

Correlation Coefficient

Capital Expenditures

Change To Account Receivables

ENDRA Life fundamental ratios Correlations

ENDRA Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ENDRA Life fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Common Stock Shares Outstanding	+ 0.99	Non Current Assets Total
Total Current Assets	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Current Liabilities
Net Tangible Assets	+ 0.98	Total Stockholder Equity

Capital Surpluse	- 0.98	Retained Earnings
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Common Stock Total Equity	- 0.97	Retained Earnings
Total Current Assets	- 0.96	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings